chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial information received on 20 October 2014 from a consumer, who is the patient's daughter. A 92 year old female patient with an unknown medical history was vaccinated on 30 September 2014 with INFLUENZA HIGH DOSE, batch number, route and site of administration not reported. It was unknown if the patient had any illness at the time of vaccination or pre-existing physician diagnosed allergies or medical conditions. On an unspecified date a few days later, the patient experienced aches all over, decreased eating and increased sleeping. She not feel well after the flu shot and laid around for two weeks. Three weeks later on an unspecified date she went to the hospital and was diagnosed with "early pneumonia" in the left lower lobe. Laboratory tests were not reported. She was prescribed antibiotics and was discharged on 20 October 2014. The patient outcome was not recovered. Documents held by sender: None.
pt recv vax 9SEP97 & noticed an unusual amount of hair loss;also notice bruising on arms;no tx given;bruising resolved;pt noted that hair was thinning prior to vax;
No additional AE reported; A patient was accidently administered VARIVAX via intramuscular route; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender. The patients' concurrent conditions, medical history, concomitant therapies and historical drug were not provided.  On 25-OCT-2012, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U019903, expiration date: 24-JUN-2023, administered intramuscularly (Incorrect route of product administration) for prophylaxis (strength, dosage not reported was not provided).  No additional adverse events were reported.
The day after the 2nd moderna Covid-19 Vaccine, the patient had red, itchy hands and then she would periodically have an itchy scalp and and red itchy chest.  Patient said the itchiness was mostly in her hands though. She said it would go away with benadryl but it would always come back when the benadryl wore off.  Patient is still having an issue on 4/8/21 when she reported it to me.
Severe radiating right shoulder pain starting on 11/28/21. Small rash on underside of right forearm beginning on 12/1/21 that slowly spread upwards. Medical care sought on 12/3/21 at Urgent Care. Shingles was diagnosed.
Extreme fatigue 3-16 hours after injection, fatigue 16+ hours after injection - treated with sleep Mild headache 12+ hours after injection - untreated, went away within 2 hours of onset Extreme arm soreness starting 3 hours after injection - treated with Celebrex and Tylenol and periodic stretching
pt with lightheadedness after 30 min wait after covid vaccine.   rechecked and noted to have "white light" vision. RN notified. patient brought back to procedure room for monitoring. transferred to gurney. vitals taken. noted shakey, but states she gets shakey sometimes. noted staring gaze for a moment.  went to get MD. noted to have unresponsiveness for a couple seconds.   sternum rub to stimulate. MD to bedside and 911 initiated.
Elevated BP; Headache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of BLOOD PRESSURE INCREASED (Elevated BP) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Elevated BP) and HEADACHE (Headache). At the time of the report, BLOOD PRESSURE INCREASED (Elevated BP) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: Valid information received
Flushing, increased heart rate,  increased blood pressure, restlessness, feels unable to sit still.  Symptoms began on 10/27 and have persisted and worsened.
Pt.awoke next morning with large red itchy welts on inner aspect of thighs, back of legs near hamstring and back of calves.  Injection site was bruised, swollen with a hard lump. Pt. was encouraged to contact her MD and discuss events. Denied any changes in diet, soaps, clothes, medications, etc. Spoke with pt again 3/5/04 reinforced need to contact her MD for documentation /evalution of risk vs benefits of receiving last series dose, even if welts are subsiding. Pt.has taken no medication. Denies any breathing difficulty.
The patient had a legal complaint. An attorney reported that a male child received a series of the following vaccines: Acel-Imune (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed), Tetramune (diptheria and tetanus toxoids and pertussis vaccine and haemophilus b conjugate vaccine) haemophilus B conjugate vaccine, Orimune (poliovirus vaccine live oral trivalent), MMR-II (measles, mumps and rubella vaccine), Engerix-B (hepatitis B vaccine) and Varivax (varicella virus vaccine live) vaccines. It is alleged that, as a result of the cumulative exposure  of Thimerosol in the vaccines he received from 2 months of age until 18 months of age, the patient experienced mercury poisoning. This case was considered serious since mercury poisoning was considered medically important in this case.
severe pain in arm and shoulder. Lack of mobility, weakness and numb/tingling fingers. Internal bruising on underside of arm.
Narrative: Symptoms:  Myalgia & Feeling bad, Tested + for COVID-19 per Pharmacy, got from family member Treatment:
Patient's mother came to Health Department and showed a picture of child's arm. She stated that swelling, redness, and severe itching on right arm occurred on 3/15/23 when child woke up in the morning. Pt's mother took child to ER on 3/15/23 and was informed by ER MD child had a possible allergic reaction to vaccine. Child was given benadryl and prescribed another medication for the reaction but mother is unable to recall name.
I had burning with the actual injection.  It burned as it went in and went down a small ways into my left arm.  The rest of the day I had the normal symptoms- Pounding headache, nausea, horrible body aches (couldn?t lay down or stand to be comfortable).  That night around 11:45pm I got up to let my dog in and I started seeing small black dots- blurry vision.  I felt nauseas.  I ended up falling on the floor.  I was able to get up.  I then ended up waking up in the bathroom on the floor and had no idea how I had gotten there.  My hands were vibrating.  I called my husband from work to come help me up.  I was able to sleep and didn?t seek medical attention.  I am not sure if it was low blood pressure or what could have happened I have never experienced that before.  I did contact my doctor?s office this afternoon via (online) but haven?t had a response yet.  I have been in bed all day today.  - Body aches, nausea, pounding headache
Body aches; Terrible headache; Pain started in her back; Pain / shin, legs and calves; Like deep sore muscle pain; 1st dose 9/21/2020 - 2nd dose 11/03/2020; This case was reported by a pharmacist via call center representative and described the occurrence of general body pain in a 57-year-old female patient who received Herpes zoster (Shingrix) (batch number 33TL7, expiry date 30th September 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 3rd November 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 3rd November 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On 4th November 2020, the patient experienced general body pain, headache, back pain, pain of lower extremities and muscle pain. On an unknown date, the outcome of the general body pain and headache were not recovered/not resolved and the outcome of the back pain, pain of lower extremities, muscle pain and drug dose administration interval too short were unknown.   The reporter considered the general body pain to be related to Shingrix. It was unknown if the reporter considered the headache, back pain, pain of lower extremities and muscle pain to be related to Shingrix.  Additional details were provided as follows: On 23rd September 2020, the patient received 1st dose of Shingrix. On 3rd November 2020, the patient received 2nd dose of Shingrix in the left deltoid, which led to shortening of vaccination schedule. The patient had body aches and a terrible headache. One day after the vaccination the pain started in her back, shin, legs and calves like deep sore muscle pain. It's worse when she first wakes up in the morning and she suffered periodically during the day. She likens it to a cold without symptoms such as runny nose. The patient stated it did seem to be getting better.
ALLERGIC REACTION, INIT 10/4/2022 FALSE LABOR BEFORE 37 WEEKS, THIRD TRIMESTER ALLERGIC REACTION, INIT 10/4/2022 OLIGOHYDRAMNIOS, THIRD TRIMESTER, SINGLETON/UNSPECIFIED FETUS
Three projectile vomiting within 20 minutes of receipt of injection. Showing signs on hand pain, irritability, signs tongue hurt. Fever for 24 hours- 102.5. Drank little water and did not want to eat.
Pt states he got a rash, starting at wrists, spread to arms, legs, and trunk. It is itchy-feels better with CALADRYL. Could be unrelated but wanted to report.
Tired and sore at injection site:  same day 10/19/2016: Tired, dizzy, feeling like passing out next day  Still sore at injection site and increasingly sore on arms and legs. 10/20/2016: Tired, sore at injection site, increasingly sore arms and legs, pain in right hip when walking.
HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 15-MAY-2021 11:30 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. Concomitant medications included ibuprofen, paracetamol, prednisone, and tramadol.  On 15-MAY-2021, the subject experienced headache. Laboratory data (dates unspecified) included: Brain CT (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
not feeling well; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "not feeling well".  Additional Information: The report is cross referenced to report ID: withheld. Warm transfer from agent withheld Pfizer (name withheld) has a caller who took the Covid shot and did not feel well. Stated that he was told that the shot may have been expired. Information confirmed as provided. Stated that his son got the vaccine and was not feeling well and recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Day after vac, babysitter noted welts all over child - notified parents & said child had a high temp. When parent got child to MD shortly after - MD documented afebrile. Child had generalized welts- welts gone by 11JAN.
This spontaneous report was received from a certified medical assistant concerning a 17 year old patient of unknown gender. On an unknown date, a 17 year old patient was vaccinated with a dose of PROQUAD (Merck) (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. No adverse effect was reported. Additional information has been requested.
Lightheadedness, Nausea, Chest Pain, Joint Aches and Pains,
The patient called me on the phone and wanted to report a rash that had recently developed on her arm around the area where she received a Shingrix vaccine a couple weeks prior. The patient  reported a non-painful, non-irritable rash that went from the area of injection down to her elbow and slightly wrapped around her arm. She stated that the first night it appeared that the rash was slightly raised but it has since gone down and is no longer raised. She stated that she has not recently changed any of her at-home routines including lotions or other topical products. I counseled her that the rash may be going away on its own, but if it were to grow in size, become worse, or start becoming painful/irritable that she should seek medical aid from her doctor.
small rash on right inner forearm; Tiny blisters on index finger; redness and skin peeled on index finger; inflammation on left wrist; itching on left wrist; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (inflammation on left wrist), PRURITUS (itching on left wrist), BLISTER (Tiny blisters on index finger), ERYTHEMA (redness and skin peeled on index finger) and RASH (small rash on right inner forearm) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included APIXABAN (ELIQUIS), FUROSEMIDE and POTASSIUM CHLORIDE (KLOR CON) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced INFLAMMATION (inflammation on left wrist), PRURITUS (itching on left wrist) and VACCINATION SITE PAIN (soreness at injection site). On 03-Mar-2021, the patient experienced BLISTER (Tiny blisters on index finger) and ERYTHEMA (redness and skin peeled on index finger). On 06-Mar-2021, the patient experienced RASH (small rash on right inner forearm). On 03-Mar-2021, VACCINATION SITE PAIN (soreness at injection site) had resolved. At the time of the report, INFLAMMATION (inflammation on left wrist), PRURITUS (itching on left wrist), BLISTER (Tiny blisters on index finger), ERYTHEMA (redness and skin peeled on index finger) and RASH (small rash on right inner forearm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication includes skin cream and diphenhydramine.
No adverse event; Patient received 0.25 ml instead of 0.5 ml of the Bivalent Booster; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25 ml instead of 0.5 ml of the Bivalent Booster) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 11-Nov-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25 ml instead of 0.5 ml of the Bivalent Booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25 ml instead of 0.5 ml of the Bivalent Booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received 0.25 ml instead of 0.5 ml of the Bivalent Booster).    Concomitant medications were not reported.  27 adult patients received pediatric dose of Bivalent  COVID-19 vaccine 0.25 ml instead of 0.5 ml.                                  No treatment information was provided by the reporter.  This case contains information for the 26 of 27 adult patients described by the reporter.
PATIENT RECEIVED VACCINE UNDER AGE.  UNABLE TO VERIFY ACCURATE DOB
On 11/Oct/2006, a report was received, via a company representative, concerning a 63-year-old female. No details were provided regarding the vaccinee's medical history or concomitant medications. On 10/Oct/2006 the vaccinee received Fluvirin, intramuscularly. On the same day, 10/Oct/2006, the vaccinee also received a pneumonia vaccine. The following day, the vaccinee experienced a raised blood glucose of 300. Follow-up information will sought. A follow-up report was received from a healthcare professional on 27/Mar/2007, concerning a 63-year-old female vaccinee. The vaccinee has a history of diabetes, blister following oral administration of Statins in 2003, Ovary Ooperectomy in 1997, Gallbladder removal in 1996 and Tonsillectomy and Adenoidectomy in 1955. The vaccinee's concomitant medications include Humalog, 60u once a day, subcutaneously for diabetes, since 1997, Humalein, 160u once a day, subcutaneously for diabetes, since 1987, Acupril for spill protein 20 mg once a day, orally since 1999. Lasix, 1 tablet once a day, orally as a diuretic, from 2006 and Zetia, 1 tablet once a day, orally for raised cholesterol from 2005 to 2006. On 10/Oct/2006 the vaccinee received Fluvirin. On the same day, 10/Oct/2006, the vaccinee also received Pneumovax 0.5ml intramuscularly into her right deltoid. The following day, 11/Oct/2006, the vaccinee experienced a raised blood sugar level of 294. The vaccinee had fasted prior to administration of the test. The symptoms have resolved. The reporter considers the event to be serious, however her causal assessment is unknown. Follow-up information will be sought.
Breathing problems starting Feb 25th, approx 2PM, escalating until Mar 1st when patient went to Walk-In Clinic for immediate care. Her oxygen saturation level was found to be in the upper 80's percentage. Was then taken by ambulance to Hospital and given oxygen. At hospital she was given a blood thinner drip. Also performed CT scan and found blood clots in her lungs. She was released to return home approx 24 hrs later with blood thinner pills (Eliquis) and at-home oxygen generation. These were necessary for approx two weeks until her O2 levels returned to normal without supplemental O2.
some chills; did not feel that well; Initial information regarding an unsolicited valid non-serious case was received from a non-healthcare professional (son/daughter of patient) on 23-Oct-2020.  This case concerns an unknown age male patient who had some chills (Chills) and did not feel that well (Malaise), after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), past medical history, concomitant vaccination (s), vaccination(s) and family history were not provided.  On 19-Oct-2020, the patient received a dose of suspect INFLUENZA VACCINE produced by an unknown manufacturer [lot number and expiry date not reported] via an unknown route in an unknown administration site for prophylactic vaccination.  On 19-Oct-2020, after few hours on the same day following administration of the suspect vaccine dose, the patient had some chills (Chills) and did not feel that well (Malaise).  No laboratory details were reported.  It was not reported if the patient received a corrective treatment.  The patient recovered from all the reported events on an unknown date.  There will be no information on the batch number to be requested for this case.
Patient had stable ITP on IVIG, promacta for a few years. 2-3 months post Moderna covid vaccine, developed severe exacerbation of ITP requiring Rituxan and platelet transfusion. Now slightly improving.
pt recv vax;fever for 3 days peaking at 105.5;fussiness;appetite depressed;
COVID 19 Treatment; COVID 19 Treatment; Vaccine brand=Pfizer / BioNTech, Vaccine administration date=21Sep2022 / Vaccine brand Other=Moderna, Vaccine administration date=02Apr2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 as dose 5 (booster), single (Lot number: GJ2524) at the age of 51 years, in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 13Feb2021 as dose 1, single (Lot number: 007M20A), in right arm, on 13Mar2021 as dose 2, single (Lot number: 040A21A), in right arm, on 26Oct2021 as dose 3 (booster), single (Lot number: 032F21A), in right arm and on 02Apr2022 as dose 4 (booster), single (Lot number: 002M21A), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing); "Known allergies: Brazil nuts" (unspecified if ongoing); "Known allergies: latex" (unspecified if ongoing); "Suspected Mitochondrial disease" (unspecified if ongoing); "autonomic dysfunction" (unspecified if ongoing); "reactive hypoglycemia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 21Sep2022, outcome "recovered", described as "Vaccine brand=Pfizer / BioNTech, Vaccine administration date=21Sep2022 / Vaccine brand Other=Moderna, Vaccine administration date=02Apr2022"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.Clinical course: Patient had Paxlovid Treatment from 05Aug2023 to 09Aug2023; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300279918 Same patient, different product, different event;
continuous spasming across middle back to left kidney area, groin area, random spasming in abdomen area, lower chest; no treatment as of yet
Client fell out of chair and hit his head. Began to seizure Left arm pain after pfizer injection. EMS called
Broke out in a red itchy raised rash. It has since been diagnosed by my dermatologist as dermatographism. This is a new condition for me, and has been ongoing since the onset of symptoms, which is just over a week now.
SOB, generalized weakness, nauseous,  fevers, headache, cough.